Government Supported Benefits

Post Test and CE-registration

Atypical Use in Patients with Government Supported Benefits

Speaker: Jennifer Polinski

  1. Drug Budgets for Medicaid have increased from 1997 through 2002 on average:

    a. 5%
    b. 10%
    c. 15%
    d. 20%
    e. 30%

  2. Prior Authorization (PA) for Atypical Antipsychotics is standard practice for Medicaid programs. PA is utilized to:

    a. deccrease utilization
    b. contain cost
    c. monitor safety
    d. require prescribing expertise
    e. all of the above

  3. States with PA policies for Atypical Antipsychotics generally had smaller percentages of drug spending in this category than those states that did not have a PA policy.

    a. true
    b. false

Speaker: Dale Christensen

  1. Which study hypothesis is NOT a suspected characteristic of Second Generation Atypical (SGA) Medications:

    a. SGA are probably more effective in treating negative symptoms with fewer Extra Pyramidal Symptoms than First Generation Atypicals (FGA)
    b. SGA’s offer cost savings when compared to FGA’s primarily due to reduce hospitalization
    c. There a very few head to head post marketing studies comparing SGA’s in terms of total cost over long periods of time
    d. FGA’s when compared to SGA’s seem to have greater metabolic side effects (obesity, diabetes)
    e. There is no conclusive evidence for choosing one SGA over another based in terms of cost outcomes

  2. Olanzepine and Risperidone differed in terms of treatment costs and total costs.

    a. true
    b. false

  3. Olanzepine was associated with higher medication costs but lower other medical care costs including ER, inpatient and nursing home services.

    a. true
    b. false

Speaker: Jeff Guo

  1. Metabolic Syndrome Prevalence comparison in the CATIE trial population and NHANES trial population showed:

    a. CATIE had greater prevalence than NHANES
    b. CATIE has a lesser prevalence than NHANES
    c. CATIE and NHANES had equivalent prevalence
    d. CATIE and NHANES were not compared

  2. The metabolism of atypical antipsychotics is an important factor in assessing adverse drug events (ADE’s). Which of the following is false about atypical antipsychotic metabolism:

    a. Metabolism in general takes place in the liver
    b. Cytochrome P450 inhibition is not an important factor
    c. Competitive inhibition of liver enzymes can cause increased ADE’s
    d. Increased EPS activity can be caused by higher plasma levels of atypicals

  3. Drug induced diabetes in Bipolar Disease patients taking atypical antipsychotics shows:

    a. Increased risk of diabetes in study populations
    b. Decreased risk of diabetes in study populations
    c. No difference in risk between control and study populations

Your supplied information will be treated in a confidential manner and will not be released to any third parties except in a non-identified summary form. Your name, degree(s), and email address, is required in order to issue your CE certificate, and will not be used for any other purpose. Any additional information supplied is optional.
   
First Name:
Last Name:
Degree(s):
Primary Practice Location:
City:
State and Zip:
Email Address:
  (your certificate will be sent to this address)